首页> 外国专利> Cross-linked injectable hydrogel in situ and its preparation and use procedure

Cross-linked injectable hydrogel in situ and its preparation and use procedure

机译:原位交联可注射水凝胶及其制备和使用方法

摘要

A method for preparing a crosslinked hydrogel, injectable in situ, characterized in that: it comprises the following steps: (1) packaging an active crosslinking solution in a container for injection of the hydrogel, in which case the active solution that can be crosslinked contains at least one type of biocompatible macromolecules, which has two thiol groups in the side chain; (2) seal the container containing the active crosslinking solution; and (3) oxidize the thiol groups to disulfide bonds to form the crosslinked hydrogel by dissolved oxygen in the crosslinkable active solution in the sealed container; and the biocompatible macromolecule with more than two thiol groups in the side chain is a derivative of polysaccharides or proteins produced by one or more chemical modifications that include at least one thiol modification.
机译:一种原位注射的交联水凝胶的制备方法,其特征在于:包括以下步骤:(1)将活性交联溶液包装在注射水凝胶的容器中,在这种情况下,可以交联的活性溶液包含至少一种类型的生物相容性大分子,其在侧链具有两个巯基; (2)密封装有活性交联溶液的容器; (3)在密闭容器中的可交联活性溶液中,通过溶解的氧将硫醇基氧化成二硫键而形成交联水凝胶。且在侧链中具有两个以上巯基的生物相容性大分子是通过一种或多种化学修饰产生的多糖或蛋白质的衍生物,所述化学修饰包括至少一种巯基修饰。

著录项

  • 公开/公告号ES2664269T3

    专利类型

  • 公开/公告日2018-04-18

    原文格式PDF

  • 申请/专利权人 BIOREGEN BIOMEDICAL (CHANGZHOU) CO. LTD.;

    申请/专利号ES20090820182T

  • 发明设计人 SHU XIAOZHENG;

    申请日2009-09-08

  • 分类号C08J3/24;A61K9;A61L27/52;A61L27/54;A61L31/14;A61L31/16;C08J3/075;

  • 国家 ES

  • 入库时间 2022-08-21 12:48:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号